Hitoshi Tajiri
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Hepatitis B Virus Infection Status in Japanese Children Prior to Universal Vaccination: Sustained Effectiveness of Mother-to-Child Transmission Prevention and Residual Infection Burden.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: December 28, 2025
Safety and Effectiveness of Glecaprevir/Pibrentasvir in Children and Adolescents With Chronic Hepatitis C: Reports From All-Case Post-Marketing Surveillance in Japan.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: November 11, 2025
Efficacy and Safety of Glecaprevir/Pibrentasvir in Children Aged 3-11 Years With Chronic Hepatitis C: A Real-World, Prospective, Multicenter Study in Japan.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 12, 2025
Growth impairment in Japanese children with inflammatory bowel disease: A multicenter prospective cohort study.
Journal: Journal of pediatric gastroenterology and nutrition
Published: February 23, 2025
Natural history and clinical features of hepatitis C virus infection during childhood: A nationwide, observational survey in Japan.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: September 23, 2023
Clinical outcome of ulcerative colitis with severe onset in children: a multicenter prospective cohort study.
Journal: Journal of gastroenterology
Published: December 30, 2022
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study.
Journal: Journal of gastroenterology
Published: October 17, 2022
The impact of treatment on the psychological burden of mothers of children with chronic hepatitis C virus infection: a multicenter, questionnaire survey.
Journal: Scientific reports
Published: April 19, 2022
Correction: Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan.
Journal: PloS one
Published: April 19, 2022
The role of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in the assessment of fibrosis in children with chronic hepatitis C.
Journal: Scientific reports
Published: November 17, 2021
Last Updated: 09/26/2026